Business Description
Amrutanjan Health Care Ltd
ISIN : INE098F01031
Compare
Compare
Traded in other countries / regions
AMRUTANJAN.India IPO Date
2015-01-02Description
Amrutanjan Health Care Ltd manufactures Ayurvedic and allopathic products. The company operates through the following segments: OTC Products, Beverages, and Others. The majority of the revenue is generated from its OTC segment which is engaged in the manufacturing products of pain management, congestion management, and hygiene. Its beverage segment includes manufacturing fruit juices and oral rehydration drinks. Some of its products include Roll-on, Spray, Balm, Cough Syrup, Sanitary napkin, and inhaler. Geographically, it generates the majority of the revenue from India.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 307.67 | |||||
| Equity-to-Asset | 0.74 | |||||
| Debt-to-EBITDA | 0.01 | |||||
| Interest Coverage | 340.96 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 14.98 | |||||
| Beneish M-Score | -1.99 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 13.3 | |||||
| 3-Year EBITDA Growth Rate | 14.7 | |||||
| 3-Year EPS without NRI Growth Rate | 17.9 | |||||
| 3-Year FCF Growth Rate | -13 | |||||
| 3-Year Book Growth Rate | 22.3 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 82.04 | |||||
| 9-Day RSI | 78.51 | |||||
| 14-Day RSI | 75.14 | |||||
| 6-1 Month Momentum % | 7.34 | |||||
| 12-1 Month Momentum % | 7.01 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.22 | |||||
| Quick Ratio | 2.86 | |||||
| Cash Ratio | 2.4 | |||||
| Days Inventory | 55.04 | |||||
| Days Sales Outstanding | 35.07 | |||||
| Days Payable | 106.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.59 | |||||
| Dividend Payout Ratio | 0.3 | |||||
| 3-Year Dividend Growth Rate | 13.5 | |||||
| Forward Dividend Yield % | 0.72 | |||||
| 5-Year Yield-on-Cost % | 1.44 | |||||
| 3-Year Average Share Buyback Ratio | 0.1 | |||||
| Shareholder Yield % | 0.68 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 49.49 | |||||
| Operating Margin % | 10.81 | |||||
| Net Margin % | 11.16 | |||||
| FCF Margin % | 2.61 | |||||
| ROE % | 15.99 | |||||
| ROA % | 12.16 | |||||
| ROIC % | 28.75 | |||||
| ROC (Joel Greenblatt) % | 120.38 | |||||
| ROCE % | 20.8 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 45 | |||||
| PE Ratio without NRI | 45 | |||||
| Shiller PE Ratio | 53.64 | |||||
| Price-to-Owner-Earnings | 70.07 | |||||
| PEG Ratio | 2.43 | |||||
| PS Ratio | 5.03 | |||||
| PB Ratio | 7.5 | |||||
| Price-to-Tangible-Book | 8.61 | |||||
| Price-to-Free-Cash-Flow | 193.37 | |||||
| Price-to-Operating-Cash-Flow | 103.54 | |||||
| EV-to-EBIT | 34.56 | |||||
| EV-to-EBITDA | 31.43 | |||||
| EV-to-Revenue | 5.17 | |||||
| EV-to-FCF | 171.29 | |||||
| Price-to-Projected-FCF | 3.63 | |||||
| Price-to-DCF (Earnings Based) | 2.45 | |||||
| Price-to-DCF (FCF Based) | 16.8 | |||||
| Price-to-Peter-Lynch-Fair-Value | 3.58 | |||||
| Price-to-Graham-Number | 4.82 | |||||
| Price-to-Net-Current-Asset-Value | 12.27 | |||||
| Price-to-Net-Cash | 20 | |||||
| Earnings Yield (Greenblatt) % | 2.89 | |||||
| FCF Yield % | 0.46 | |||||
| Forward Rate of Return (Yacktman) % | 20.03 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Amrutanjan Health Care Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 3,943.852 | ||
| EPS (TTM) (₹) | 15.13 | ||
| Beta | 0.61 | ||
| Volatility % | 31.23 | ||
| 14-Day RSI | 75.14 | ||
| 14-Day ATR (₹) | 25.064947 | ||
| 20-Day SMA (₹) | 682.1 | ||
| 12-1 Month Momentum % | 7.01 | ||
| 52-Week Range (₹) | 563.9 - 804 | ||
| Shares Outstanding (Mil) | 28.89 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Amrutanjan Health Care Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Amrutanjan Health Care Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Amrutanjan Health Care Ltd Frequently Asked Questions
What is Amrutanjan Health Care Ltd(NSE:AMRUTANJAN)'s stock price today?
The current price of NSE:AMRUTANJAN is ₹775.75. The 52 week high of NSE:AMRUTANJAN is ₹804.00 and 52 week low is ₹563.90.
When is next earnings date of Amrutanjan Health Care Ltd(NSE:AMRUTANJAN)?
The next earnings date of Amrutanjan Health Care Ltd(NSE:AMRUTANJAN) is .
Does Amrutanjan Health Care Ltd(NSE:AMRUTANJAN) pay dividends? If so, how much?
The Dividend Yield %  of Amrutanjan Health Care Ltd(NSE:AMRUTANJAN) is 0.59% (As of Today), Highest Dividend Payout Ratio of Amrutanjan Health Care Ltd(NSE:AMRUTANJAN) was 0.41. The lowest was 0.08. And the median was 0.31. The  Forward Dividend Yield % of Amrutanjan Health Care Ltd(NSE:AMRUTANJAN) is 0.72%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers